Cargando…

An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis

INTRODUCTION: Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of this study was to clarify which of four different low-dose anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Skagerlind, Malin S. E., Stegmayr, Bernd G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808085/
https://www.ncbi.nlm.nih.gov/pubmed/29198062
http://dx.doi.org/10.1007/s00228-017-2389-x
_version_ 1783299397125144576
author Skagerlind, Malin S. E.
Stegmayr, Bernd G.
author_facet Skagerlind, Malin S. E.
Stegmayr, Bernd G.
author_sort Skagerlind, Malin S. E.
collection PubMed
description INTRODUCTION: Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of this study was to clarify which of four different low-dose anticoagulant modes was preferable in reducing the exposure to i.v. unfractionated heparin (heparin) and maintaining patency of the dialysis circuit. METHODS: Twenty-three patients on SHD were included to perform haemodialysis with four modes of low-dose anticoagulation. For comparative analyses, patients served as their own control. Haemodialysis with a single bolus of tinzaparin at the start was compared to haemodialysis initiated without i.v. heparin but priming with (1) heparin in saline (H), (2) heparin and albumin in saline (HA), (3) heparin and albumin in combination with a citrate-containing dialysate (HAC), (4) saline and usinga heparin-coated filters (Evodial®). The priming fluid was discarded before dialysis started. Blood samples were collected at 0, 30 and 180 min during haemodialysis. Smaller bolus doses of heparin (500 Units/dose) were allowed during the modes to avoid interruption by clotting. FINDINGS: The mean activated partial thromboplastin (APTT) time as well as the doses of anticoagulation administered was highest with SHD and least with HAC and Evodial®. Mode H versus SHD had the highest rate of prematurely interrupted dialyses (33%, p = 0.008). The urea reduction rate was less with Evodial® vs. SHD (p < 0.01). One hypersensitivity reaction occurred with Evodial®. Changes in blood cell concentrations and triglycerides differed between the modes. DISCUSSION: If intermittent haemodialysis is necessary in patients at risk of bleeding, anticoagulation using HAC and Evodial® appeared most preferable with least administration of heparin, lowest APTT increase and lowest risk for prematurely clotted dialyzers in contrast to the least plausible H mode. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00228-017-2389-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5808085
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58080852018-02-22 An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis Skagerlind, Malin S. E. Stegmayr, Bernd G. Eur J Clin Pharmacol Clinical Trial INTRODUCTION: Intensive care participants that need dialysis frequently suffer from increased risk of bleeding. Standard intermittent haemodialysis (SHD) includes anticoagulation to avoid clotting of the dialysis system. The aim of this study was to clarify which of four different low-dose anticoagulant modes was preferable in reducing the exposure to i.v. unfractionated heparin (heparin) and maintaining patency of the dialysis circuit. METHODS: Twenty-three patients on SHD were included to perform haemodialysis with four modes of low-dose anticoagulation. For comparative analyses, patients served as their own control. Haemodialysis with a single bolus of tinzaparin at the start was compared to haemodialysis initiated without i.v. heparin but priming with (1) heparin in saline (H), (2) heparin and albumin in saline (HA), (3) heparin and albumin in combination with a citrate-containing dialysate (HAC), (4) saline and usinga heparin-coated filters (Evodial®). The priming fluid was discarded before dialysis started. Blood samples were collected at 0, 30 and 180 min during haemodialysis. Smaller bolus doses of heparin (500 Units/dose) were allowed during the modes to avoid interruption by clotting. FINDINGS: The mean activated partial thromboplastin (APTT) time as well as the doses of anticoagulation administered was highest with SHD and least with HAC and Evodial®. Mode H versus SHD had the highest rate of prematurely interrupted dialyses (33%, p = 0.008). The urea reduction rate was less with Evodial® vs. SHD (p < 0.01). One hypersensitivity reaction occurred with Evodial®. Changes in blood cell concentrations and triglycerides differed between the modes. DISCUSSION: If intermittent haemodialysis is necessary in patients at risk of bleeding, anticoagulation using HAC and Evodial® appeared most preferable with least administration of heparin, lowest APTT increase and lowest risk for prematurely clotted dialyzers in contrast to the least plausible H mode. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00228-017-2389-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-12-02 2018 /pmc/articles/PMC5808085/ /pubmed/29198062 http://dx.doi.org/10.1007/s00228-017-2389-x Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Trial
Skagerlind, Malin S. E.
Stegmayr, Bernd G.
An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title_full An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title_fullStr An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title_full_unstemmed An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title_short An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
title_sort evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis
topic Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808085/
https://www.ncbi.nlm.nih.gov/pubmed/29198062
http://dx.doi.org/10.1007/s00228-017-2389-x
work_keys_str_mv AT skagerlindmalinse anevaluationoffourmodesoflowdoseanticoagulationduringintermittenthaemodialysis
AT stegmayrberndg anevaluationoffourmodesoflowdoseanticoagulationduringintermittenthaemodialysis
AT skagerlindmalinse evaluationoffourmodesoflowdoseanticoagulationduringintermittenthaemodialysis
AT stegmayrberndg evaluationoffourmodesoflowdoseanticoagulationduringintermittenthaemodialysis